Differential Effects of Progenitor Cell Populations on Left Ventricular Remodeling and Myocardial Neovascularization After Myocardial Infarction
Christophe Dubois(KU Leuven), Stefan Janssens(Maastricht University), Sara Vandenwijngaert(Massachusetts General Hospital), Marinee Chuah(Vrije Universiteit Brussel), Witold Streb, Hilde Gillijns(Ghent University), D Collen(VIB-KU Leuven Center for Cancer Biology), Frederik Maes(Universitair Ziekenhuis Leuven), Hélène Depelteau(Universitair Ziekenhuis Leuven), Zeger Debyser(KU Leuven), Xiaoshun Liu(Vlaams Instituut voor Biotechnologie), Glenn Marsboom(Johnson & Johnson (United States)), Frans Van de Werf(KU Leuven), Jan Bogaert(KU Leuven), Lertlak Chaothawee(Universitair Ziekenhuis Leuven), Ann Belmans(KU Leuven), Thierry VandenDriessche(Vrije Universiteit Brussel), Marijke Pellens(Ghent University), Piet Claus(Universitair Ziekenhuis Leuven), Olivier Gheysens(Cliniques Universitaires Saint-Luc), Erik Verbeken, Péter Pokreisz(Ghent University)
Cited by 116
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k